Regeneron announces agreement with barda supporting development of next-generation antibody therapy for covid-19 prevention

Program is part of u.s. government's ‘project nextgen' and provides partial funding for clinical development of a novel monoclonal antibody therapy program is part of u.s. government's ‘project nextgen' and provides partial funding for clinical development of a novel monoclonal antibody therapy
REGN Ratings Summary
REGN Quant Ranking